The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 31, 2019

Filed:

Feb. 19, 2016
Applicant:

Mello Biotechnology, Inc., Santa Fe Springs, CA (US);

Inventors:

Chih-Li Lin, Taichung, TW;

Hsin-Hua Li, Taichung, TW;

Shi-Lung Lin, Arcadia, CA (US);

Te-Jen Lai, Taichung, TW;

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); C12N 5/0793 (2010.01); C12N 5/10 (2006.01); C12N 15/63 (2006.01); C12N 1/38 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); C12N 5/0619 (2013.01); C12N 5/10 (2013.01); C12N 15/63 (2013.01); C12N 1/38 (2013.01); C12N 15/635 (2013.01); C12N 2310/141 (2013.01); C12N 2310/531 (2013.01);
Abstract

This invention generally relates to a composition and method of using recombinant microRNAs (miRNA) and their hairpin-like precursors (pre-miRNA) as therapeutic drugs for treating Alzheimer's diseases (AD). More specifically, the present invention relates to the use of man-made miRNA miR-302 precursors (pre-miR-302) for AD therapy in humans. These pre-miR-302 molecules can be mass produced in prokaryotes as a form of DNA expression-competent DNA vectors and/or hairpin-like RNAs. As prokaryotic cells do not transcribe or process hairpin-like RNAs, the present invention also teaches a method for expressing pre-miRNAs in prokaryotes, i.e. pro-miRNA, using a novel hairpin-like RNA transcription mechanism newly found in prokaryotes. Additionally, since miR-302 is a well-known embryonic stem cell (ESC)-specific factor in humans, our novel findings of this invention can be further used to advance the designs and development of novel regenerative medicine for treating many other ageing-related degenerative diseases, such as Parkinson's diseases, osteoporosis, diabetes, and cancers.


Find Patent Forward Citations

Loading…